EUCTR2012-002764-27-IT进行中（未招募）1 期
A European Multicentre Double-Blind Placebo Controlled trial of Nilvadipine in Mild to Moderate Alzheimer's desease - NILVAD
ST. JAMES HOSPITA0 个研究点目标入组 511 人开始时间: 2013年2月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 511
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients older than 50 years with a diagnosis of Alzheimer's disease according to the NINCDS-ADRDA criteria with a SMMSE test score greater than or equal to 12 and minor than 27.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 45
排除标准
- •Subjects treated with calcium-antagonists or beta-blokers, with significant renal or liver impairment, history of significant cardiovascular diseases, such as miocardial infarction or unstable angina. Patients without a caregiver.
研究者
相似试验
进行中（未招募）
1 期
A clinical trial to investigate the effectiveness of the drug Nilvadipine to treat mild to moderate Alzheimer's disease.Mild to Moderate Alzheimer's DiseaseMedDRA version: 16.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2012-002764-27-SESt James's Hospital500
进行中（未招募）
1 期
A clinical trial to investigate the effectiveness of the drug Nilvadipine to treat mild to moderate Alzheimer's disease.Mild to Moderate Alzheimer's DiseaseMedDRA version: 14.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852EUCTR2012-002764-27-GBSt James's Hospital511
进行中（未招募）
1 期
A clinical trial to investigate the effectiveness of the drug Nilvadipine to treat mild to moderate Alzheimer's disease.EUCTR2012-002764-27-NLSt James's Hospital500
进行中（未招募）
1 期
A clinical trial to investigate the effectiveness of the drug Nilvadipine to treat mild to moderate Alzheimer's disease.EUCTR2012-002764-27-HUSt James's Hospital500
进行中（未招募）
1 期
A clinical trial to investigate the effectiveness of the drug Nilvadipine to treat mild to moderate Alzheimer's disease.Mild to Moderate Alzheimer's DiseaseMedDRA version: 14.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2012-002764-27-IESt James's Hospital500